Management of Neurotrophic Corneal Ulcer: About a Case Report
Author: LM. Hmidchat, A. El jai, L. Bonin
Category: JMSR Ophtalmology
Abstract:
Persistent or recurrent corneal ulcers are among the most difficult ophthalmological conditions to treat and may potentially result in blindness. In the absence of healing, they progress toward corneal perforation or total "de novo" vascularization. Although the clinical diagnosis may be made easily, the management can be quite challenging. Novel therapies recently being investigated are beginning to show promise in the treatment of the non healing corneal epithelium.
Keywords: Neurotrophic corneal ulcer, Treatment
References:
Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014 Mar: 19;8: 571-9.
Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation.Br J Ophthalmol. 2001 Dec;85(12):1455-63.
Sanchez-Avila RM, Merayo- Lloves J, Riestra AC, Fernandez-Vega Cueto L, Anitua E, Begoña L, Muruzabal F, Orive G. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops. Int Ophthalmol. 2017 Jun 15.doi: 10.1007/s10792-017-0582-7.
Sacchetti M, Lambiase A. Neurotrophic factors and corneal nerve regeneration. Neural Regen Res. 2017 Aug; 12 (8):1220-1224.
Vera L, Benzerroug M, Gueudry J, Varin R, Haghighat S, Gérard G, Muraine M. An update on the use of tissue adhesives in ophthalmology. J Fr Ophtalmol. 2009 Apr; 32(4):290-305.
Jhanji V, Young AL, Mehta JS, Sharma N, Agarwal T, Vajpayee RB. Management of corneal perforation. Surv Ophthalmol. 2011; 56: 522 - 538.